|
AczoneDrug - Aczone The trade name of the product as shown on the labeling.
Dosage -
GEL; TOPICAL
Active Ingredient(s) -
Dapsone
Strength -
5%
Applicant -
QLT USA
New Drug Application (NDA) Number -
021794
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 7, 2005
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Qlt Usa Inc
Aczone
Rev-eyes 0.5% Solution/drops; Ophthalmic
Aczone 5% Gel; Topical Dantrium 50mg Capsule; Oral Dantrolene Sodium 100mg Capsule; Oral Dantrolene Sodium 25mg Capsule; Oral Dantrolene Sodium 50mg Capsule; Oral Dantrolene Sodium 100mg Capsule; Oral Dantrolene Sodium 25mg Capsule; Oral Dantrolene Sodium 50mg Capsule; Oral Dantrium 20mg/vial Injectable; Injection NewDrugInformation |